| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.2M | +0.8% | +19.1% |
| Cost of Revenue | $10.8M | +1.5% | +22.3% |
| Gross Profit | $1.4M | -4.5% | -0.5% |
| R&D Expense | $6.7M | +3.0% | -5.9% |
| SG&A Expense | $10.5M | +30.6% | -14.9% |
| Operating Income | -$18.2M | -17.9% | -1.1% |
| Net Income | -$26.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.2M | +17.3% | +1855.5% |
| Accounts Receivable | $2.4M | -0.6% | +18.6% |
| Inventory | $6.8M | -2.9% | +4.2% |
| Current Assets | $24.1M | -3.3% | +39.5% |
| Total Assets | $417.8M | -2.1% | -3.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.2M | — | — |
| Capital Expenditures | $12.1M | — | — |
| Investing Cash Flow | -$12.1M | — | — |
| Financing Cash Flow | $44.5M | — | — |
| Free Cash Flow | -$39.3M | — | — |
| -22.5% |
| +23.0% |
| EPS (Basic) | -$1.18 | +27.6% | +70.6% |
| EPS (Diluted) | -$1.18 | +27.6% | +70.6% |
| $14.3M |
| -26.1% |
| -73.1% |
| Long-term Debt | $484.9M | +1.4% | +21.7% |
| Total Liabilities | $575.9M | +2.9% | +16.0% |
| Stockholders' Equity | -$158.1M | -19.2% | -141.0% |